Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. |
| |
| Authors: | Rola Husni Ray Hachem Hend Hanna Issam Raad |
| |
| Affiliation: | The University of Texas M.D. Anderson Cancer Center, Department of Infectious Diseases, Infection Control and Employee Health, Houston, Texas 77030, USA. |
| |
| Abstract: | To determine the risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer, we conducted a case-control study. According to multivariate analysis, the only significant factors were neutropenia (< 500 cells/mm3) for more than 1 week and the use of oral vancomycin. Therefore, colonized neutropenic patients with cancer who have previously used oral vancomycin are most prone to VRE infection. |
| |
| Keywords: | |
|
|
